Niva Bupa Health Insurance Company Limited (NIVABUPA) Q1 Results FY27 Preview: Date, Time, Expectations & Key Things To Watch

CompoundingAI Research Updated July 25, 2026 3 min read

Niva Bupa Health Insurance enters Q1 FY27 with strong momentum, having achieved a 10.1% retail health market share by the end of FY26. Investors will be closely watching the impact of the new Ind AS accounting transition on reported margins and whether the company can sustain its sub-100% Combined Insurance Service Ratio (CISR) in a typically high-acquisition quarter.

Quick Details

Results date	July 30, 2026
Quarter	Q1 FY 2026-2027
Previous quarter revenue	Rs. 3,123.4 Cr
Previous quarter PAT	Rs. 157.8 Cr
Previous quarter EBITDA margin	97.4%
Market cap	Rs. 16,021.76 Cr
CMP	Rs. 86.64

Niva Bupa Health Insurance Company Limited Q1 Results Date and Time

The board meeting is scheduled for July 30, 2026, to consider the Q1 FY27 financial results.

What to expect from Niva Bupa Health Insurance Company Limited's Q1 FY27 results

Niva Bupa enters the new fiscal year following a strong FY26 performance where retail health GWP grew 35.0% to Rs. 6,581.5 Cr. The company's strategy to offset medical inflation through annual single-digit price increases remains a core focus, especially as the IFRS claims ratio rose to 64.9% in FY26. Management has maintained a long-term retail industry growth outlook of 17%–19% CAGR, which provides a structural tailwind for the firm's expansion. The transition to Ind AS accounting starting this quarter is expected to improve transparency, though it may introduce volatility compared to previous IFRS reporting. The upcoming call will likely focus on the sustainability of the sub-100% CISR achieved in Q4 FY26 and the status of regulatory forbearance for prior-year expense limits.

Key Things To Watch

Performance vs Guidance Tracking: Tracking progress against long-term strategic targets.

GWP scale target of Rs. 15,000–16,000 Cr by FY28–FY29
Combined ratio target of ~99% by FY29
ROE target of mid-to-high teens by FY29

Operating metric trajectory: Tracking the efficiency of the retail health business.

Sustainability of sub-100% CISR (Q4 FY26 was 97.4%)
Retail health loss ratio trajectory relative to the FY26 level of 66.8%
SME group health growth pace, targeting ~50% growth

Strategic execution and regulatory updates: Key governance and operational milestones.

IFRS 17 / Ind AS transition impact on earnings comparability
Status of IRDAI approval for FY25 EOM forbearance
Cashless SLA recovery post-resolution of auto-adjudication issues

Frequently Asked Questions

What was Niva Bupa's retail health market share at the end of FY26?

Niva Bupa's retail health market share reached 10.1% at the end of FY26, up from 9.4% in FY25. This growth was supported by a 35.0% YoY increase in retail health GWP.

What is the status of the company's Combined Insurance Service Ratio (CISR)?

The CISR improved by 160 bps in FY26 to 101.4%, with the company achieving a sub-100% ratio of 97.4% for the first time in Q4 FY26. Management is focused on sustaining this profitability level while managing acquisition costs.